Although lentivirus could efficiently deliver shRNA into mammalian cells and silencing USP39 in carcinoma cells, targeted gene delivery methods are need to be developed to specifically knockdown USP39 expression in tumor cells. The gene discussed is USP39; the disease is carcinoma.